HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.87 CAD -0.61%
Market Cap: 152.3m CAD

Wall Street
Price Targets

HLS Price Targets Summary
HLS Therapeutics Inc

Wall Street analysts forecast HLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HLS is 7.6 CAD with a low forecast of 4.04 CAD and a high forecast of 12.6 CAD.

Lowest
Price Target
4.04 CAD
17% Downside
Average
Price Target
7.6 CAD
56% Upside
Highest
Price Target
12.6 CAD
159% Upside
HLS Therapeutics Inc Competitors:
Price Targets
PHARMA
Pharmaniaga Bhd
12% Downside
SIG
Sigma Healthcare Ltd
14% Upside
FAGR
Fagron NV
25% Upside
0HF3
Amerisourcebergen Corp
15% Upside
MCK
Mckesson Corp
18% Upside

Revenue
Forecast

Revenue Estimate
HLS Therapeutics Inc

For the last 13 years the compound annual growth rate for HLS Therapeutics Inc's revenue is -3%. The projected CAGR for the next 4 years is 4%.

-3%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
HLS Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
HLS Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HLS's stock price target?
Price Target
7.6 CAD

According to Wall Street analysts, the average 1-year price target for HLS is 7.6 CAD with a low forecast of 4.04 CAD and a high forecast of 12.6 CAD.

What is HLS Therapeutics Inc's Revenue forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for HLS Therapeutics Inc's revenue is -3%. The projected CAGR for the next 4 years is 4%.

Back to Top